Clinafloxacin CAS:105956-97-6
Clinafloxacin is prescribed for bacterial infections such as pneumonia, bronchitis, sinusitis, urinary tract infections, skin infections, and sexually transmitted diseases caused by susceptible pathogens. Healthcare providers determine the appropriate dosage, frequency, and duration of treatment based on the type and severity of the infection, patient factors, and susceptibility testing results. Patients should take clinafloxacin as directed by their healthcare provider, typically with a full glass of water and without food to optimize absorption. It is important to complete the full course of treatment even if symptoms improve before completion to ensure eradication of the infecting bacteria and to reduce the risk of antibiotic resistance. Monitoring for potential side effects such as gastrointestinal upset, dizziness, or allergic reactions is essential during clinafloxacin therapy. Patients experiencing severe symptoms or concerning reactions should seek medical advice promptly for evaluation and appropriate management. When used correctly and under medical supervision, clinafloxacin plays a crucial role in effectively treating bacterial infections and promoting patient recovery.
Composition | C17H17ClFN3O3 |
Assay | 99% |
Appearance | white powder |
CAS No. | 105956-97-6 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |